{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:16:52Z","timestamp":1787671012057,"version":"build-2736575974"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"UK Department of Health\u2019s NIHR Biomedical Research Centres"},{"name":"Dr Marvin Weil Epilepsy Research Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.seizure.2018.11.012","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:46:27Z","timestamp":1544013987000},"page":"59-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Seizures as a clinical manifestation in somatic autoimmune disorders"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1197-0833","authenticated-orcid":false,"given":"Man","family":"Amanat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland D.","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6041-9661","authenticated-orcid":false,"given":"Josemir W.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2018.11.012_bib0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.seizure.2016.08.003","article-title":"Association between epilepsy and systemic autoimmune diseases: a meta-analysis","volume":"41","author":"Lin","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2018.11.012_bib0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000121423","article-title":"Clinical description of seizures in patients with systemic lupus erythematosus","volume":"59","author":"Gonz\u00e1lez-Duarte","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.17219\/acem\/43585","article-title":"Celiac disease and epilepsy: the effect of gluten-free diet on seizure control","volume":"25","author":"Bashiri","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.seizure.2018.11.012_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0887-8994(99)00006-5","article-title":"Pediatric manifestations of hashimoto\u2019s encephalopathy","volume":"20","author":"Vasconcellos","year":"1999","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1525-5050(02)00646-7","article-title":"Epilepsy and multiple sclerosis","volume":"4","author":"Poser","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.11.012_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eplepsyres.2015.05.008","article-title":"Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: prevalence and clinical characteristics","volume":"115","author":"Keezer","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.11.012_bib0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","article-title":"Population-level evidence for an autoimmune etiology of epilepsy","volume":"71","author":"Ong","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.coph.2015.11.002","article-title":"Modulation of neuronal excitability by immune mediators in epilepsy","volume":"26","author":"Iori","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nbd.2015.07.003","article-title":"GABAA currents are decreased by IL-1\u03b2 in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis","volume":"82","author":"Roseti","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.seizure.2018.11.012_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/revneuro-2013-0045","article-title":"Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: systematic review and meta-analysis","volume":"25","author":"Saghazadeh","year":"2014","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neubiorev.2016.02.007","article-title":"Inflammatory mediators in human epilepsy: a systematic review and meta-analysis","volume":"63","author":"de Vries","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.seizure.2018.11.012_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.braindev.2005.09.004","article-title":"Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders","volume":"28","author":"Inutsuka","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2018.11.012_bib0070","article-title":"Treatment of infantile spasms","volume":"6","author":"Hancock","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2018.11.012_bib0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yebeh.2013.09.029","article-title":"Early life stress in epilepsy: a seizure precipitant and risk factor for epileptogenesis","volume":"38","author":"van Campen","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.11.012_bib0080","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/brain\/aww071","article-title":"Cortisol fluctuations relate to interictal epileptiform discharges in stress sensitive epilepsy","volume":"139","author":"Van Campen","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2018.11.012_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/epi.13947","article-title":"The relation between cortisol and functional connectivity in people with and without stress\u2010sensitive epilepsy","volume":"59","author":"Heijer","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5698\/1535-7511.17.3.134","article-title":"\u201cAutoimmune epilepsy\u201d: encephalitis with autoantibodies for epileptologists","volume":"17","author":"Bien","year":"2017","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2018.11.012_bib0095","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3174\/ajnr.A5086","article-title":"Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis","volume":"38","author":"Kelley","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0100","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2018.11.012_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2018.01.007","article-title":"Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: a comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus","volume":"317","author":"Nakajima","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/db06-1275","article-title":"An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes","volume":"56","author":"Masia","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.seizure.2018.11.012_bib0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/0883073809343313","article-title":"Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease","volume":"25","author":"Hopkins","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0135","first-page":"407","article-title":"Ketoacidosis accompanied by epileptic seizures in a patient with diabetes mellitus and mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)","volume":"26","author":"Nakamura","year":"2000","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.seizure.2018.11.012_bib0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gene.2014.01.027","article-title":"A complex microcephaly syndrome in a Pakistani family associated with a novel missense mutation in RBBP8 and a heterozygous deletion in NRXN1","volume":"538","author":"Agha","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.seizure.2018.11.012_bib0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ejhg.2013.87","article-title":"A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient","volume":"22","author":"Sanyoura","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.seizure.2018.11.012_bib0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/pedi.12086","article-title":"Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder","volume":"15","author":"Shalev","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.seizure.2018.11.012_bib0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/seiz.2001.0600","article-title":"The 677C\u2192 T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus","volume":"11","author":"Afeltra","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2018.11.012_bib0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.seizure.2018.11.012_bib0165","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00415-016-8228-7","article-title":"Epilepsy and tobacco smoking: a cross-sectional study","volume":"263","author":"Torriani","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0170","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/01.WNL.0000154639.35941.21","article-title":"Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen","volume":"64","author":"Schuele","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.seizure.2018.11.012_bib0180","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.12.002","article-title":"Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study","volume":"32","author":"Briani","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.seizure.2018.11.012_bib0190","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2147\/NDT.S64323","article-title":"Risk of epilepsy in patients with systemic lupus erythematosus\u2013a retrospective cohort study","volume":"10","author":"Tsai","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.seizure.2018.11.012_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000485136","article-title":"Epilepsy among systemic lupus erythematosus patients: insights from a large database analysis","volume":"50","author":"Watad","year":"2018","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0200","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/annrheumdis-2011-201089","article-title":"Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study","volume":"71","author":"Hanly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.seizure.2018.11.012_bib0205","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jmii.2014.05.001","article-title":"Comorbidities of pediatric systemic lupus erythematosus: a 6-year nationwide population-based study","volume":"49","author":"Chan","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.seizure.2018.11.012_bib0210","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0215","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/01.WNL.0000165959.98370.D5","article-title":"Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus","volume":"64","author":"Mikdashi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0220","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.150135","article-title":"Predictors of incident seizure in systemic lupus erythematosus","author":"Huang","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0225","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/art.1780381016","article-title":"Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort","volume":"38","author":"Ward","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"1369","key":"10.1016\/j.seizure.2018.11.012_bib0230","article-title":"Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus","volume":"25","author":"Ferreira","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.seizure.2018.11.012_bib0235","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000168","article-title":"Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies","volume":"1","author":"Holmqvist","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.seizure.2018.11.012_bib0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.21483","article-title":"Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients","volume":"64","author":"Appenzeller","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0245","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/eci.12744","article-title":"The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis","volume":"47","author":"Tiosano","year":"2017","journal-title":"Eur J Clin Invest"},{"issue":"33","key":"10.1016\/j.seizure.2018.11.012_bib0250","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10067-013-2312-5","article-title":"Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011","author":"Jiang","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0255","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp.2005.084285","article-title":"Detection of cerebral embolic signals in patients with systemic lupus erythematosus","volume":"77","author":"Dahl","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2018.11.012_bib0260","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000047970","article-title":"Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus","volume":"47","author":"Kumral","year":"2002","journal-title":"Eur Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0265","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/epi.12012","article-title":"Mesial temporal lobe epilepsy as a neuropsychiatric syndrome of systemic lupus erythematosus","volume":"54","author":"Toyota","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0270","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s00415-014-7406-8","article-title":"Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review","volume":"26","author":"Sciascia","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0275","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.seizure.2018.11.012_bib0280","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1038\/s41598-017-08099-3","article-title":"Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.seizure.2018.11.012_bib0285","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0961203307083365","article-title":"Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients","volume":"16","author":"Malik","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.seizure.2018.11.012_bib0290","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00125-016-4142-x","article-title":"Type I diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study","volume":"60","author":"Dafoulas","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0295","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00125-016-3929-0","article-title":"Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study","volume":"59","author":"Chou","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0300","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00125-016-3982-8","article-title":"The intriguing relationship between epilepsy and type 1 diabetes mellitus","volume":"59","author":"Sander","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20727","article-title":"An association between type 1 diabetes and idiopathic generalized epilepsy","volume":"59","author":"McCorry","year":"2006","journal-title":"Annals Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0310","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/EJE-12-0699","article-title":"Seizures and type 1 diabetes mellitus: current state of knowledge","volume":"167","author":"Verrotti","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0315","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jns.2014.08.024","article-title":"Hypoglycemic seizures and epilepsy in type I diabetes mellitus","volume":"346","author":"Falip","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1528-1167.2011.03030.x","article-title":"Systemic and neurologic autoimmune disorders associated with seizures or epilepsy","volume":"52","author":"Vincent","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s100720200055","article-title":"Glutamic acid decarboxylase autoantibodies and neurological disorders","volume":"23","author":"Vianello","year":"2002","journal-title":"Neurol Sci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0330","first-page":"281","article-title":"Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes","volume":"80","author":"Elkadhi","year":"2002","journal-title":"Tunis Med"},{"key":"10.1016\/j.seizure.2018.11.012_bib0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13023-018-0787-5","article-title":"GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies","volume":"13","author":"Liimatainen","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.seizure.2018.11.012_bib0340","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/pedi.12346","article-title":"Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies","volume":"17","author":"Ganelin\u2010Cohen","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.seizure.2018.11.012_bib0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yebeh.2018.03.004","article-title":"Anti-GAD antibodies in a cohort of neuropsychiatric patients","volume":"82","author":"Vinke","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.11.012_bib0350","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jocn.2017.06.067","article-title":"Treatment of epilepsy in patients with myasthenia gravis: Is really harder than it looks?","volume":"44","author":"Lorenzoni","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0355","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"Uzawa","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0360","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrgastro.2015.136","article-title":"Coeliac disease and autoimmune disease\u2014genetic overlap and screening","volume":"12","author":"Lundin","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0365","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/mds.22821","article-title":"Neurological symptoms in patients with biopsy proven celiac disease","volume":"24","author":"Burk","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.seizure.2018.11.012_bib0370","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.0013-9580.2004.54104.x","article-title":"The prevalence of epilepsy in patients with celiac disease","volume":"45","author":"Pengiran Tengah","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0375","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/qjmed\/91.4.303","article-title":"Coeliac disease and epilepsy","volume":"91","author":"Cronin","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.seizure.2018.11.012_bib0380","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1542\/peds.113.6.1672","article-title":"Range of neurologic disorders in patients with celiac disease","volume":"113","author":"Zelnik","year":"2004","journal-title":"Pediatr"},{"key":"10.1016\/j.seizure.2018.11.012_bib0385","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/bmj.2.6132.250","article-title":"Increased prevalence of epilepsy in coeliac disease","volume":"2","author":"Chapman","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.seizure.2018.11.012_bib0390","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1212\/WNL.0b013e3182544728","article-title":"Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study","volume":"78","author":"Ludvigsson","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0395","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.0013-9580.2004.54104.x","article-title":"The prevalence of epilepsy in patients with celiac disease","volume":"45","author":"Tengah","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0400","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1056\/NEJMicm1311406","article-title":"Occipital calcification and celiac disease","volume":"370","author":"Cury","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2018.11.012_bib0405","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pediatrneurol.2014.01.021","article-title":"Prevalence of celiac disease in children with idiopathic epilepsy in southeast Turkey","volume":"50","author":"I\u015f\u0131kay","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.braindev.2004.05.003","article-title":"Coeliac disease, epilepsy and cerebral calcifications","volume":"27","author":"Gobbi","year":"2005","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2018.11.012_bib0415","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3109\/00207454.2014.983227","article-title":"Cryptogenic focal epilepsy and\" hidden\" celiac disease in adulthood: a causal or accidental link?","volume":"125","author":"Casciato","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0420","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.4049\/jimmunol.178.10.6590","article-title":"Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I","volume":"178","author":"Alaedini","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0425","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/ene.13564","article-title":"Persistent mucosal damage and the risk of epilepsy in people with celiac disease","volume":"25","author":"Kurien","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0430","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1097\/MD.0000000000001485","article-title":"A large-scale study indicates increase in the risk of epilepsy in patients with different risk factors, including rheumatoid arthritis","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.seizure.2018.11.012_bib0435","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbspin.2012.06.014","article-title":"Isolated rheumatoid arthritis-associated cerebral vasculitis: a diagnostic challenge","volume":"80","author":"Loya-de la Cerda","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.seizure.2018.11.012_bib0440","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1212\/WNL.0000000000000366","article-title":"Rheumatoid meningitis presenting with stroke-like episodes","volume":"82","author":"Bourgeois","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0445","first-page":"1632","article-title":"Seizure and methotrexate therapy in rheumatoid arthritis","volume":"20","author":"Thomas","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0450","first-page":"748","article-title":"Sulfasalazine induced seizures and dysphasia","volume":"21","author":"Hill","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0455","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1212\/WNL.0000000000003424","article-title":"Parental rheumatoid arthritis and childhood epilepsy: a nationwide cohort study","volume":"87","author":"Rom","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0460","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.psym.2010.12.010","article-title":"Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) or Hashimoto\u2019s encephalopathy: a case and review","volume":"52","author":"Lee","year":"2011","journal-title":"Psychosomatics"},{"issue":"87","key":"10.1016\/j.seizure.2018.11.012_bib0465","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, t(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III)","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.seizure.2018.11.012_bib0470","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0475","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.autrev.2016.01.014","article-title":"Hashimoto\u2019s encephalopathy: a rare proteiform disorder","volume":"15","author":"Montagna","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"159","key":"10.1016\/j.seizure.2018.11.012_bib0480","first-page":"1116","article-title":"Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis","author":"Gerdes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0485","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1515\/revneuro-2017-0108","article-title":"Neurological and psychiatric disorders in psoriasis","volume":"29","author":"Amanat","year":"2018","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0490","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2018.11.012_bib0495","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jama.1952.03680100032010","article-title":"Convulsions as manifestation of multiple sclerosis","volume":"150","author":"Williams","year":"1952","journal-title":"JAMA"},{"key":"10.1016\/j.seizure.2018.11.012_bib0500","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1528-1157.1999.tb00772.x","article-title":"Risk of epilepsy in patients with multiple sclerosis: a population\u2010based study in Iceland","volume":"40","author":"Olafsson","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0505","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/nyas.12841","article-title":"Pathological differences between white and grey matter multiple sclerosis lesions","volume":"1351","author":"Prins","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0510","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrn3900","article-title":"Exploring the origins of grey matter damage in multiple sclerosis","volume":"16","author":"Calabrese","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0515","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11310900-000000000-00000","article-title":"Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management","volume":"23","author":"Kelley","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2018.11.012_bib0520","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10072-016-2803-7","article-title":"Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis","volume":"38","author":"Gasparini","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0525","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.seizure.2017.09.022","article-title":"The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway","volume":"52","author":"Benjaminsen","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2018.11.012_bib0530","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ane.12276","article-title":"Multiple sclerosis and seizures: incidence and prevalence over 40 years","volume":"130","author":"Lund","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2018.11.012_bib0535","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1352458516651502","article-title":"Epilepsy in multiple sclerosis: the role of temporal lobe damage","volume":"23","author":"Calabrese","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.seizure.2018.11.012_bib0540","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.eplepsyres.2012.09.005","article-title":"Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica","volume":"104","author":"Nakano","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.11.012_bib0545","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainresbull.2017.02.011","article-title":"The role of aquaporin-4 in synaptic plasticity, memory and disease","volume":"136","author":"Hubbard","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.seizure.2018.11.012_bib0550","doi-asserted-by":"crossref","first-page":"P4","DOI":"10.1212\/WNL.84.14_supplement.P4.065","article-title":"Patient with established, Seropositive Neuromyelitis Optica presenting in Status Epilepticus due to NMDA receptor antibodies","volume":"84","author":"Kumar","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.11.012_bib0555","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0560","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","article-title":"A population-based study of the association between bullous pemphigoid and neurologic disorders","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0565","first-page":"230","article-title":"Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid?","volume":"11","author":"Foureur","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0570","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","article-title":"The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0575","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population\u2010based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0580","first-page":"81","article-title":"The association between bullous pemphigoid and neurological disorders in a selected Malaysian population","volume":"70","author":"Kwan","year":"2015","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.seizure.2018.11.012_bib0585","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/0378-6323.191132","article-title":"Neurological diseases and bullous pemphigoid: a case\u2013control study in Iranian patients","volume":"83","author":"Daneshpazhooh","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0590","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng0795-301","article-title":"The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1","volume":"10","author":"Brown","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.seizure.2018.11.012_bib0595","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rdc.2015.08.005","article-title":"Glucocorticoid-induced osteoporosis","volume":"42","author":"Whittier","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.seizure.2018.11.012_bib0600","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000098","article-title":"Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus","volume":"3","author":"Carli","year":"2016","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.seizure.2018.11.012_bib0605","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yebeh.2004.02.005","article-title":"Antiepileptic drugs and reduced bone mineral density","volume":"5","author":"Ali","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.11.012_bib0610","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bmj.320.7242.1113","article-title":"Worsening of symptoms of multiple sclerosis associated with carbamazepine","volume":"320","author":"Ramsaransing","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2018.11.012_bib0615","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10072-004-0362-9","article-title":"Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study","volume":"25","author":"Solaro","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1016\/j.seizure.2018.11.012_bib0620","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population\u2010based matched case\u2013control study of 234 patients in Sweden","volume":"167","author":"Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.seizure.2018.11.012_bib0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J Clin Neurol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118305892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118305892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:51:53Z","timestamp":1761011513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118305892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":125,"alternative-id":["S1059131118305892"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2018.11.012","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizures as a clinical manifestation in somatic autoimmune disorders","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2018.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}